CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 300 of 434 entries

View as:

A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients

Phase: N/A Priority: Normal

NCT ID: NCT00654940 Org: User:

Start: 05/31/08 End: 02/28/09 Due: 02/28/10

A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers

Phase: N/A Priority: Normal

NCT ID: NCT00813241 Org: User:

Start: 01/31/09 End: 03/31/09 Due: 03/31/10

A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Phase: N/A Priority: Normal

NCT ID: NCT01389596 Org: User:

Start: 09/27/11 End: 08/10/16 Due: 08/10/17

NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark

Phase: N/A Priority: Normal

NCT ID: NCT01524796 Org: User:

Start: 01/31/12 End: 03/31/14 Due: 03/31/15

Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction

Phase: N/A Priority: Normal

NCT ID: NCT00147654 Org: User:

Start: 11/30/04 End: 05/31/06 Due: 05/31/07

A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis

Phase: N/A Priority: Normal

NCT ID: NCT00644800 Org: User:

Start: 07/31/03 End: 05/31/04 Due: 05/31/05

An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

Phase: N/A Priority: Normal

NCT ID: NCT00372528 Org: User:

Start: 03/31/07 End: 10/31/11 Due: 10/31/12

To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks

Phase: N/A Priority: Normal

NCT ID: NCT00946114 Org: User:

Start: 06/30/06 End: 03/31/09 Due: 03/31/10

Compliance With Treatment For Patients With Hyperlipidemia

Phase: N/A Priority: Normal

NCT ID: NCT00828945 Org: User:

Start: 02/28/09 End: 03/31/11 Due: 03/31/12

Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance

Phase: N/A Priority: Normal

NCT ID: NCT00991276 Org: User:

Start: 12/31/09 End: 06/30/11 Due: 06/30/12

Mild To Moderate Erectile Dysfunction Study

Phase: N/A Priority: Normal

NCT ID: NCT00137072 Org: User:

Start: 04/30/05 End: 02/28/06 Due: 02/28/07

A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain

Phase: N/A Priority: Normal

NCT ID: NCT00631943 Org: User:

Start: 11/30/04 End: 03/31/05 Due: 03/31/06

A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment

Phase: N/A Priority: Normal

NCT ID: NCT00785772 Org: User:

Start: 03/31/10 End: 04/30/10 Due: 04/30/11

Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal

NCT ID: NCT00762463 Org: User:

Start: 07/31/09 End: 08/31/10 Due: 08/31/11

A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance

Phase: N/A Priority: Normal

NCT ID: NCT00666939 Org: User:

Start: 10/31/04 End: 01/31/05 Due: 01/31/06

Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet

Phase: N/A Priority: Normal

NCT ID: NCT00950404 Org: User:

Start: 08/31/09 End: 09/30/09 Due: 09/30/10

A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

Phase: N/A Priority: Normal

NCT ID: NCT00667108 Org: User:

Start: 10/31/04 End: 01/31/05 Due: 01/31/06

A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients

Phase: N/A Priority: Normal

NCT ID: NCT00645372 Org: User:

Start: 07/31/04 End: 05/31/05 Due: 05/31/06

A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets

Phase: N/A Priority: Normal

NCT ID: NCT01322867 Org: User:

Start: 05/31/11 End: 09/30/11 Due: 09/30/12

A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate

Phase: N/A Priority: Normal

NCT ID: NCT00904748 Org: User:

Start: 01/31/10 End: 03/31/10 Due: 03/31/11

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

Phase: N/A Priority: Normal

NCT ID: NCT00483548 Org: User:

Start: 10/31/07 End: 12/31/08 Due: 12/31/09

Special Investigation Of J Zoloft For Panic Disorder Patients

Phase: N/A Priority: Normal

NCT ID: NCT00605917 Org: User:

Start: 04/30/07 End: 09/30/11 Due: 09/30/12

Pregabalin Peripheral Neuropathic Pain Study

Phase: N/A Priority: Normal

NCT ID: NCT00141219 Org: User:

Start: 12/31/05 End: 12/31/07 Due: 12/31/08

A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal

NCT ID: NCT00553280 Org: User:

Start: 02/29/08 End: 01/31/10 Due: 01/31/11

A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice

Phase: N/A Priority: Normal

NCT ID: NCT00855738 Org: User:

Start: 05/31/07 End: 06/30/09 Due: 06/30/10

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients	NCT00654940	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-05-31	2009-02-28	2010-02-28	-	-	2025-07-14
A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers	NCT00813241	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-01-31	2009-03-31	2010-03-31	-	-	2025-07-14
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years	NCT01389596	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-09-27	2016-08-10	2017-08-10	-	-	2025-07-14
NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark	NCT01524796	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2012-01-31	2014-03-31	2015-03-31	-	-	2025-07-14
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction	NCT00147654	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-11-30	2006-05-31	2007-05-31	-	-	2025-07-14
A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis	NCT00644800	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-07-31	2004-05-31	2005-05-31	-	-	2025-07-14
An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures	NCT00372528	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-03-31	2011-10-31	2012-10-31	-	-	2025-07-14
To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks	NCT00946114	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-06-30	2009-03-31	2010-03-31	-	-	2025-07-14
Compliance With Treatment For Patients With Hyperlipidemia	NCT00828945	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-02-28	2011-03-31	2012-03-31	-	-	2025-07-14
Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance	NCT00991276	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-12-31	2011-06-30	2012-06-30	-	-	2025-07-14
Mild To Moderate Erectile Dysfunction Study	NCT00137072	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-04-30	2006-02-28	2007-02-28	-	-	2025-07-14
A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain	NCT00631943	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-11-30	2005-03-31	2006-03-31	-	-	2025-07-14
A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment	NCT00785772	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-03-31	2010-04-30	2011-04-30	-	-	2025-07-14
Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis	NCT00762463	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-07-31	2010-08-31	2011-08-31	-	-	2025-07-14
A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance	NCT00666939	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-10-31	2005-01-31	2006-01-31	-	-	2025-07-14
Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet	NCT00950404	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-08-31	2009-09-30	2010-09-30	-	-	2025-07-14
A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance	NCT00667108	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-10-31	2005-01-31	2006-01-31	-	-	2025-07-14
A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients	NCT00645372	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-07-31	2005-05-31	2006-05-31	-	-	2025-07-14
A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets	NCT01322867	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-05-31	2011-09-30	2012-09-30	-	-	2025-07-14
A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate	NCT00904748	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-01-31	2010-03-31	2011-03-31	-	-	2025-07-14
Adjunctive Ziprasidone in the Treatment of Bipolar I Depression	NCT00483548	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-10-31	2008-12-31	2009-12-31	-	-	2025-07-14
Special Investigation Of J Zoloft For Panic Disorder Patients	NCT00605917	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-04-30	2011-09-30	2012-09-30	-	-	2025-07-14
Pregabalin Peripheral Neuropathic Pain Study	NCT00141219	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-12-31	2007-12-31	2008-12-31	-	-	2025-07-14
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy	NCT00553280	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-02-29	2010-01-31	2011-01-31	-	-	2025-07-14
A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice	NCT00855738	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-05-31	2009-06-30	2010-06-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance